Dennis S Hooper

US Patent:

8628928, Jan 14, 2014

Filed:

Nov 6, 2012

Appl. No.:

13/669579

Inventors:

Dennis G. Hooper - Lewisville TX, US

Assignee:

Medical Service Consultation International, LLC - Carrollton TX

International Classification:

C12Q 1/00
C12Q 1/02
C12Q 1/04
C12Q 1/68

US Classification:

435 615, 435 4, 435 61, 435 611, 435 612, 435 29, 435 34

Abstract:

The invention relates to a method of identifying a specific fungal species in patient tissue or body fluid. The method comprises the steps of extracting and recovering DNA of the fungal species from the patient tissue or body fluid, amplifying the DNA, hybridizing a probe to the DNA to specifically identify the fungal species, and specifically identifying the fungal species. The invention also relates to a method of identifying a mycotoxin in patient tissue or body fluid. The method comprises the steps of extracting and recovering the mycotoxin from the patient tissue or body fluid, contacting the mycotoxin with an antibody directed against the mycotoxin, and identifying the myocotoxin. Both of these methods can be used to determine if a patient is at risk for or has developed a disease state related to a fungal infection, and to develop an effective treatment regimen for the patient.

US Patent:

20080014582, Jan 17, 2008

Filed:

Mar 30, 2007

Appl. No.:

11/731674

Inventors:

Dennis Hooper - Lewisville TX, US

International Classification:

C12Q 1/68
C07H 19/00

US Classification:

435006000, 536022100

Abstract:

The invention relates to a method of identifying a specific fungal species in patient tissue or body fluid. The method comprises the steps of extracting and recovering DNA of the fungal species from the patient tissue or body fluid, amplifying the DNA, hybridizing a probe to the DNA to specifically identify the fungal species, and specifically identifying the fungal species. The invention also relates to a method of identifying a mycotoxin in patient tissue or body fluid. The method comprises the steps of extracting and recovering the mycotoxin from the patient tissue or body fluid, contacting the mycotoxin with an antibody directed against the mycotoxin, and identifying the myocotoxin. Both of these methods can be used to determine if a patient is at risk for or has developed a disease state related to a fungal infection, and to develop an effective treatment regimen for the patient.

US Patent:

20100068718, Mar 18, 2010

Filed:

Aug 21, 2009

Appl. No.:

12/545732

Inventors:

Dennis G. Hooper - Lewisville TX, US

International Classification:

C12Q 1/68
G01N 33/53
C07H 21/00

US Classification:

435 6, 435 71, 436 86, 536 231

Abstract:

The invention relates to a method of identifying a specific yeast species in patient tissue or body fluid. The method comprises the steps of extracting and recovering DNA of the yeast species from the patient tissue or body fluid, amplifying the DNA, hybridizing a probe to the DNA to specifically identify the yeast species, and specifically identifying the yeast species. The invention also relates to a method of identifying a yeast mycotoxin in patient tissue or body fluid. The method comprises the steps of extracting and recovering the yeast mycotoxin from the patient tissue or body fluid, contacting the yeast mycotoxin with an antibody directed against the yeast mycotoxin, and identifying the yeast myocotoxin. Both of these methods can be used to determine if a patient is at risk for or has developed a disease state related to a yeast infection, and to develop an effective treatment regimen for the patient.

US Patent:

20100075322, Mar 25, 2010

Filed:

Aug 21, 2009

Appl. No.:

12/545734

Inventors:

Dennis G. Hooper - Lewisville TX, US

International Classification:

C12Q 1/68
G01N 33/566
G01N 33/53
G01N 33/48

US Classification:

435 6, 436501, 435 78, 435 405

Abstract:

The invention relates to a method of testing for a mycotoxin in patient tissue or body fluid and testing for a fungal species in the patient tissue or body fluid. The method can also be used to determine if a patient is at risk for or has developed a disease state related to a fungal infection, and to develop an effective treatment regimen for the patient.

US Patent:

20110104684, May 5, 2011

Filed:

Oct 8, 2010

Appl. No.:

12/901247

Inventors:

Dennis G. Hooper - Lewisville TX, US

International Classification:

C12Q 1/68
C07H 21/04

US Classification:

435 6, 536 2432, 536 2433

Abstract:

The invention relates to methods and compositions for identifying specific bacterial species, which are sulfur and iron oxidizers and/or reducers, from wall board (e.g., dry wall) and/or a patient tissue or body fluid. The method comprises the steps of extracting and recovering DNA of the bacterial species from the wall board and/or the patient tissue or body fluid, amplifying the DNA, hybridizing a probe to the DNA to specifically identify the bacterial species, and specifically identifying the bacterial species. Kits and nucleic acids for use in the methods are also provided. Methods for eliminating the sulfur and iron oxidizing and/or reducing bacteria from wall board using a zeolite are also provided.

US Patent:

20130183697, Jul 18, 2013

Filed:

Mar 14, 2013

Appl. No.:

13/827441

Inventors:

MEDICAL SERVICE CONSULTATION INTERNATIONAL LLC - Carollton TX, US
Dennis G. HOOPER - Lewisville TX, US

Assignee:

MEDICAL SERVICE CONSULTATION INTERNATIONAL LLC - Carollton TX

International Classification:

G01N 33/569

US Classification:

435 792, 435 71

Abstract:

The invention relates to a method of identifying a specific fungal species in patient tissue or body fluid. The method comprises the steps of extracting and recovering DNA of the fungal species from the patient tissue or body fluid, amplifying the DNA, hybridizing a probe to the DNA to specifically identify the fungal species, and specifically identifying the fungal species. The invention also relates to a method of identifying a mycotoxin in patient tissue or body fluid. The method comprises the steps of extracting and recovering the mycotoxin from the patient tissue or body fluid, contacting the mycotoxin with an antibody directed against the mycotoxin, and identifying the myocotoxin. Both of these methods can be used to determine if a patient is at risk for or has developed a disease state related to a fungal infection, and to develop an effective treatment regimen for the patient.

US Patent:

20190277848, Sep 12, 2019

Filed:

Mar 22, 2019

Appl. No.:

16/361720

Inventors:

- Carrollton TX, US
Dennis G. Hooper - Lewisville TX, US

International Classification:

G01N 33/569
C12Q 1/6895

Abstract:

The invention relates to a method of identifying a specific fungal species in patient tissue or body fluid. The method comprises the steps of extracting and recovering DNA of the fungal species from the patient tissue or body fluid, amplifying the DNA, hybridizing a probe to the DNA to specifically identify the fungal species, and specifically identifying the fungal species. The invention also relates to a method of identifying a mycotoxin in patient tissue or body fluid. The method comprises the steps of extracting and recovering the mycotoxin from the patient tissue or body fluid, contacting the mycotoxin with an antibody directed against the mycotoxin, and identifying the mycotoxin. Both of these methods can be used to determine if a patient is at risk for or has developed a disease state related to a fungal infection, and to develop an effective treatment regimen for the patient.

US Patent:

20190101534, Apr 4, 2019

Filed:

Jun 13, 2018

Appl. No.:

16/007504

Inventors:

- Carrollton TX, US
Dennis G. HOOPER - Lewisville TX, US

International Classification:

G01N 33/569
C12Q 1/6895

Abstract:

The invention relates to a method of identifying a specific fungal species in patient tissue or body fluid. The method comprises the steps of extracting and recovering DNA of the fungal species from the patient tissue or body fluid, amplifying the DNA, hybridizing a probe to the DNA to specifically identify the fungal species, and specifically identifying the fungal species. The invention also relates to a method of identifying a mycotoxin in patient tissue or body fluid. The method comprises the steps of extracting and recovering the mycotoxin from the patient tissue or body fluid, contacting the mycotoxin with an antibody directed against the mycotoxin, and identifying the myocotoxin. Both of these methods can be used to determine if a patient is at risk for or has developed a disease state related to a fungal infection, and to develop an effective treatment regimen for the patient.